Schedule 13D ownership disclosure

Keenova Therapeutics PLC

Security class unavailable · CUSIP: G5890A102

Event date: 2023-06-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-169117
Form type
SC 13D
Filer
Alta Fundamental Advisers LLC
CIK
CIK 1641604
Filed
Jun 16, 2023
Reporting period
Jun 16, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub